Intrinsic
Insights
Screener
Valuation
Movers
Economy
Bonds
Institutions
Business Summaries
Updates
Go
Sign In
Screener
Summaries
Updates
Institutions
Sign In
More
↑
Overview
Financials
Chart
Business Summary
Filings
Ownership
Valuation
BGM Group Ltd.
(BGM)
Pharmaceutical Preparations
Latest Price
$0.28
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
--
P/B Ratio
--
Valuation metrics
adjust assumptions →
Norm. op. income:
$769,116 (median of 6yr)
Tax rate:
12%
Discount rate:
10%
Growth assumption:
zero (EPV is a no-growth value)
Earnings Power Value
$0.09
69% downside
Base FCF:
$304,105 (median of recent 5yr)
Growth:
5%/yr (median YOY, capped at 25%)
Discount rate:
10%
Terminal growth:
3%
Projection horizon:
10 years
DCF Fair Value
$0.08
72% downside